Elan/Dura Shareholder Claims Rejected By Supreme Court
This article was originally published in The Pink Sheet Daily
Executive Summary
The shareholders failed to establish a causal connection between Dura’s alleged misrepresentations about the Spiros albuterol device in the late 1990s and any economic loss, the high court says in a unanimous opinion. Elan acquired Dura in 2000.